Catheter Precision, Inc.
$0.15
-$0.00 (-1.96%)
$0.14Day Range$0.15
Key Statistics
Market Cap
$541.42K
Shares Outstanding
3.6M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Sep 27, 2018
Round Lot
100
Locale
US
Trading Data
Day Open
$0.15
Day High
$0.15
Day Low
$0.14
Volume
1.11M
VWAP
$0.15
Prev Close
$0.15
Transactions
--
Acc. Volume
--
About Catheter Precision, Inc.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384117 employees1670 HIGHWAY 160 WEST, FORT MILL, SC, 29708973-691-2000IPO Sep 27, 2018US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001716621
- Composite FIGI
- BBG0029BD0V2
- Share Class FIGI
- BBG0029BD0W1
- Ticker Root
- VTAK
- SIC Code
- 3841
About Catheter Precision, Inc. (VTAK) Stock
Catheter Precision, Inc. (VTAK) closed the 2026-09-18 session at $0.15, down 1.96% versus the previous close (-0.00). The stock opened at $0.15 and traded between $0.14 and $0.15 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $0.15.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
Catheter Precision, Inc. has a market capitalization of $541,420.65. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. VTAK is listed on the XASE exchange. The company employs approximately 17 people. Catheter Precision, Inc. is headquartered in FORT MILL, SC. The recorded listing date is 2018-09-27.
On this page you can find market VTAK stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.